Notice of Special Interest (NOSI): Model-informed Drug Development (MIDD) Approaches to Facilitate the Development of Therapeutics for Substance Use Disorders
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity focuses on encouraging research using Model-informed Drug Development (MIDD) methods to create medications for substance use disorders (SUDs). There is a critical need for new and effective treatments due to the limited number of approved drugs. Traditional drug development is costly and lengthy, but MIDD offers a promising alternative by utilizing data-driven and model-based techniques to enhance decision-making. This approach can potentially expedite the drug develop…
This notice intends to inform potential applicants about a special interest in supporting research on the application of Model-informed Drug Development (MIDD) approaches for developing medications to treat substance use disorders (SUDs). Due to the limited availability of approved medications, …
Source
Grant ID
NOT-DA-26-002
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
August 27, 2024
Similar opportunities
- Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
- Notice of Special Interest (NOSI): Application of Artificial Intelligence in Treatment Development for Substance Use Disorders
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
- Notice of Special Interest (NOSI): Training Program in Application of Artificial Intelligence in Development of Treatment for Substance Use Disorders
- Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs)